Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: Albert David Limited

Market Cap 3.35B 35.13M 30.39M 28M 26.24M 49.02M 49.92M 332M 129M 1.62B 132M 129M 5.63B P/E ratio 2024
8.14x
P/E ratio 2025 26.9x
Enterprise value 1.04B 10.87M 9.4M 8.67M 8.12M 15.17M 15.45M 103M 39.89M 501M 40.82M 39.94M 1.74B EV / Sales 2024
0.92x
EV / Sales 2025 0.67x
Free-Float
35.96%
Yield 2024
1.07%
Yield 2025 0.62%
1 day+0.32%
1 week-0.98%
Current month-0.59%
1 month-12.49%
3 months+6.07%
6 months-7.54%
Current year-5.40%
1 week 687.5
Extreme 687.5
765
1 month 687.5
Extreme 687.5
805.65
Current year 581.3
Extreme 581.3
819.9
1 year 581.3
Extreme 581.3
959.35
3 years 580
Extreme 580
1,752.95
5 years 467
Extreme 467
1,752.95
10 years 255
Extreme 255
1,752.95
Manager TitleAgeSince
Chief Executive Officer 52 2026-05-11
Director of Finance/CFO - 2020-11-30
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 63 2024-11-13
Chairman 72 2009-12-29
Director/Board Member 68 2014-03-30
Date Insider Type Main position Quantity % Market Cap.
25-02-26
Kothari Phytochemicals & Industries Ltd.
BuyCompany 6,000 0.1051%
Change 5-day change 1-year change 3-year change Capi.($)
+0.32%-0.98%-17.68%+14.24% 41.77M
+0.49%+0.01%+5.92%+81.51% 44.76B
-0.10%-7.48%+40.64%+88.45% 33.76B
-0.07%+0.03%-8.95%+43.30% 11.66B
-0.70%+1.97%+11.82%+115.25% 11.67B
+0.88%+0.39%+36.90%+125.55% 8.97B
-1.06%-1.92%+17.00%+41.30% 7.01B
+0.47%+3.06%+44.13%-18.18% 6.49B
-2.91%-1.29%+32.83%+236.07% 6.54B
+0.80%-4.61%-37.90%-5.83% 5.18B
Average -0.17%-1.76%+12.47%+72.17% 13.61B
Weighted average by Cap. +0.01%-2.60%+17.81%+83.01%

Financials

2024 2025
Net sales 3.62B 38.01M 32.88M 30.3M 28.39M 53.04M 54.01M 359M 139M 1.75B 143M 140M 6.09B 3.46B 36.26M 31.37M 28.9M 27.09M 50.59M 51.52M 343M 133M 1.67B 136M 133M 5.81B
Net income 754M 7.91M 6.84M 6.3M 5.91M 11.04M 11.24M 74.78M 29.02M 365M 29.7M 29.05M 1.27B 172M 1.8M 1.56M 1.44M 1.35M 2.52M 2.56M 17.06M 6.62M 83.19M 6.77M 6.63M 289M
Net Debt -2.82B -29.56M -25.57M -23.56M -22.08M -41.25M -42M -280M -108M -1.36B -111M -109M -4.74B -2.31B -24.26M -20.99M -19.34M -18.12M -33.85M -34.47M -229M -89.01M -1.12B -91.09M -89.12M -3.89B
Logo Albert David Limited
Albert David Limited is an India-based pharmaceutical company. The Company's principal business is manufacturing and trading of pharmaceutical formulations, infusion solutions, herbal dosage forms and bulk drugs by way of domestic sale or export. Its product categories include formulations and bulk drugs. Its product range includes Placentrex range, Anaflam range and BREAZE range. Its formulations include parenteral, oral/enteral, topical agents and vision care. Its parenteral categories include amino acids infusion, anti-microbial, anti-leishmaniasis (kalazar), haemostat (inj), lvp, neurotropic vitamin and placenta extract. The Company's oral/enteral categories include amino acids oral, anthelmintic, anti-microbial, anti-ulcer ants, anti-vertigo, appetite stimulants, anti-tubercular, expectorant / cough syrup, hematinic, haemostat, hepato protective (ayurveda) and hepato protective (others). Its vision care categories include anti glaucoma, anti-infective and NSAID.
Employees
1,805
Calendar
Date Price Change Volume
26-06-10 700.05 +0.32% 34
26-06-09 697.85 +0.21% 216
26-06-08 696.40 -1.62% 358
26-06-05 707.90 -1.95% 131
26-06-04 721.95 +2.11% 22
  1. Stock Market
  2. Stocks
  3. 524075 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!